Inhibición de los efectos coagulante, fosfolipasa A2 y proteolítico del veneno de Bothrops asper por plantas usadas tradicionalmente en Centroamérica
Inhibition of the coagulant, phospholipase A2 and proteolytic effects of Bothrops asper venom by plants traditionally used in Central America

Cienc. tecnol. salud; 4 (2), 2017
Publication year: 2017

Existen pocos estudios científicos que demuestren el valor terapéutico de las plantas usadas en la medicina tradicional centroamericana para tratar el envenenamiento ofídico. En este estudio se evaluó la capacidad de los extractos etanólicos de nueve plantas de uso etnomédico en Centroamérica (Acacia hindsii, Aristolochia maxima, Bursera simaruba, Cissampelos pareira, Eryngium foetidum, Hamelia patens, Pimenta dioica, Piper peltatum y Sansevieria hyacinthoides) para inhibir el efecto coagulante del veneno de Bothrops asper. Tres de ellas (B. simaruba, E. foetidum y P. dioica) también fueron evaluadas en cuanto a su capacidad inhibitoria de los efectos fosfolipasa A2 (PLA2) y proteolítico del veneno. Las plantas fueron colectadas en Guatemala, secadas, extraídas con etanol y los efectos inhibitorios evaluados in vitro después de preincubar concentraciones variables de extracto con concentraciones fijas de veneno. Los resultados demostraron que ninguno de los extractos logró inhibir los efectos coagulante y PLA2, pero los extractos clorofilados de P. dioica y E. foetidum inhibieron efectivamente la actividad proteolítica del veneno. El tamizaje fitoquímico, mediante ensayos macro y semimicrométricos de cromatografía en capa fina, demostró la presencia de metabolitos secundarios reportados con actividad antiproteolítica (flavonoides, antocianinas, catequinas y taninos) en la composición química de los extractos de E. foetidum y P. dioica. Su efecto sobre el veneno se evaluó mediante electroforesis SDS-PAGE, demostrándose que no está mediado por degradación proteolítica de los componentes del veneno. El aislamiento y caracterización específica de sus metabolitos secundarios en futuros estudios, permitirá determinar el mecanismo de acción inhibitoria ejercido por estos extractos.
Medicinal plants have been traditionally used in Central America to treat snakebite envenomations, however, very few scientific studies aimed to demonstrate their efficacy and safety have been performed. In this study, ethanolic extracts of nine plants used in the region by traditional healers in snakebite cases (Acacia hindsii, Aristolochia maxima, Bursera simaruba, Cissampelos pareira, Eryngium foetidum, Hamelia patens, Pimenta dioica, Piper peltatum and Sansevieria hyacinthoides) were evaluated for their ability to inhibit the coagulant effect induced by the venom of the snake Bothrops asper. Three of these extracts (B. simaruba, E. foetidum and P. dioica) were also evaluated for their inhibitory effect on the phospholipase A2 (PLA2) and proteolytic activities of the venom. Plants were collected in Guatemala, dried, extracted with ethanol, and their inhibitory effects were evaluated in vitro after pre-incubation of several amounts of each extract with a challenge concentration of venom. Results showed that none of the extracts inhibited the coagulant and PLA2 effects; however, chlorophyllated extracts of E. foetidum and P. dioica effectively inhibited the proteolytic activity of the venom. Phytochemical analysis of these extracts, conducted by macrometric assays and semimicroanalysis by thin layer chromatography, identified secondary metabolites (flavones, anthocyanins, catequines and tannins) whose anti-proteolytic activities have been widely reported. SDS-PAGE analysis demonstrated that the mechanism of inhibition is not related to proteolytic degradation of the venom proteins by the plant extracts. Further studies are needed to isolate and identify the active venom inhibitory compounds of these plants, aimed to understand their mechanism of action.

More related